These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8190182)

  • 1. Acute renal failure and severe hypertension in children with renal thrombotic microangiopathy.
    Bhuyan UN; Bagga A; Srivastava RN
    Nephron; 1994; 66(3):302-6. PubMed ID: 8190182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
    Kamioka I; Nozu K; Fujita T; Kaito H; Tanaka R; Yoshiya K; Iijima K; Nakanishi K; Yoshikawa N; Matsuo M
    Pediatr Int; 2007 Apr; 49(2):196-201. PubMed ID: 17445038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal histopathology in the hemolytic-uremic syndrome following shigellosis.
    Koster FT; Boonpucknavig V; Sujaho S; Gilman RH; Rahaman MM
    Clin Nephrol; 1984 Feb; 21(2):126-33. PubMed ID: 6373079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum hemolytic uremic syndrome: a study of three cases with a review of the literature.
    Segonds A; Louradour N; Suc JM; Orfila C
    Clin Nephrol; 1979 Nov; 12(5):229-42. PubMed ID: 389509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemolytic-uremic syndrome in children and arterial hypertension].
    Habib R; Gagnadoux MF; Broyer M
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():37-43. PubMed ID: 6794528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
    Tinaztepe K; Akkök N; Tinaztepe B
    Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a new antithrombotic agent (defibrotide) in acute renal failure due to thrombotic microangiopathy.
    Bonomini V; Frascà GM; Raimondi C; Liviano D'arcangelo G; Vangelista A
    Nephron; 1985; 40(2):195-200. PubMed ID: 3839050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure with glomerular thrombosis in a patient with chronic scleroderma.
    Ricker DM; Sharma HM; Nahman NS
    Am J Kidney Dis; 1989 Dec; 14(6):524-6. PubMed ID: 2596479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of defibrotide in acute renal failure due to thrombotic microangiopathy.
    Vangelista A; Frascà GM; Raimondi C; Liviano-D'Arcangelo G; Bonomini V
    Haemostasis; 1986; 16 Suppl 1():51-4. PubMed ID: 3754836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal thrombotic microangiopathies induced by severe hypertension.
    Zhang B; Xing C; Yu X; Sun B; Zhao X; Qian J
    Hypertens Res; 2008 Mar; 31(3):479-83. PubMed ID: 18497467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemolytic-uremic syndrome with renal thrombotic microangiopathy].
    Kanfer A
    Rev Prat; 1994 May; 44(9):1205-10. PubMed ID: 7939344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The hemolytic uremic syndrome: prime reason for acute renal failure in children].
    Trippaerts M; Demaret P; Lombet J; Chantraine JM; Fraipont V; Damas F
    Rev Med Liege; 2005 Sep; 60(9):729-36. PubMed ID: 16267892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features.
    Loirat C; Sonsino E; Varga Moreno A; Pillion G; Mercier JC; Beaufils F; Mathieu H
    Acta Paediatr Scand; 1984 Jul; 73(4):505-14. PubMed ID: 6464738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy associated with the hypereosinophilic syndrome.
    Liapis H; Ho AK; Brown D; Mindel G; Gleich G
    Kidney Int; 2005 May; 67(5):1806-11. PubMed ID: 15840027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.
    Gagnadoux MF; Habib R; Gubler MC; Bacri JL; Broyer M
    Clin Nephrol; 1996 Jul; 46(1):39-41. PubMed ID: 8832149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
    Page EE; Little DJ; Vesely SK; George JN
    Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.
    van den Born BJ; van der Hoeven NV; Groot E; Lenting PJ; Meijers JC; Levi M; van Montfrans GA
    Hypertension; 2008 Apr; 51(4):862-6. PubMed ID: 18332284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA.
    Ardalan MR
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):235-44. PubMed ID: 16903637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.
    Usui J; Glezerman IG; Salvatore SP; Chandran CB; Flombaum CD; Seshan SV
    Hum Pathol; 2014 Sep; 45(9):1918-27. PubMed ID: 25087655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.